The IACH meeting is sponsored by the pharmaceutical industry via sponsorships and exhibition packages. Companies have had no further input into the arrangements, agenda or scientific content of the meeting.
IACH Annual Meeting
Sanofi
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Street: 46 Avenue de la Grande Armée,
City: 75017 PARIS
Country: FRANCE
E-mail: https://www.sanofi.com/en/contact
Website: https://www.sanofi.com/
Twitter: https://twitter.com/SanofiScience and https://twitter.com/Sanofi
Lilly
Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable.
Adaptive
Adaptive Biotechnologies is a leader in the field of immunosequencing, transforming the understanding of the immune system through cutting-edge technologies.
clonoSEQ® is a next-generation sequencing (NGS) test that enables precise and sensitive measurement of minimal residual disease (MRD) in blood cancers, such as leukemia and lymphoma. This test provides clinicians with valuable insights into disease monitoring, relapse detection, and treatment response. Now available in Europe, clonoSEQ empowers healthcare providers with advanced tools for better patient outcomes in the fight against hematologic malignancies.
Merck Sharp & Dohme LLC
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases. For more information, visit www.msd.com and connect with us on X, LinkedIn and YouTube.
Daiichi Sankyo
Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular and other diseases with high unmet medical need.
Daiichi Sankyo
Zielstattstr. 48 81379
Munich Germany
Website: https://www.daiichi-sankyo.eu/
Incyte
At Incyte, we are committed to addressing unmet medical needs through scientific excellence and innovation. Our mission, SOLVE ON., reflects our dedication to advancing cutting-edge research in oncology, hematology, inflammation and autoimmunity. We have built a diverse pipeline of targeted therapies and immunotherapies, including small molecules, monoclonal and bispecific antibodies. With an integrated approach from research to biologics manufacturing, we strive to deliver impactful therapies that improve patients’ lives.
Incyte
1801 Augustine Cut-off Wilmington,
DE 19803, United States
Tel: +1 302-498-6700
Website: https://incyte.com/
Jazz Pharmaceuticals
Jazz Pharmaceuticals plc is a global biopharmaceutical company whose purpose is to innovate and to transform the lives of patients and their families. We are dedicated to developing potentially life-changing medicines for people with serious diseases – often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules, biologics and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland had has employees around the globe, serving patients in nearly 75 countries.
September 2025
INT-OHD-2500086
Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
Learn more at https://innovativemedicine.jnj.com/emea/.
Johnson & Johnson
Janssen-Cilag GmbH
Johnson & Johnson Platz 1
41470 Neuss
Tel: +49 2137 955-0
Website: [email protected]
Takeda
At Takeda Oncology, we are united by our aspiration to cure cancer, with inspiration from patients and innovation from everywhere. Drawing on decades of leadership in oncology, we work to develop innovative treatments that enhance and extend the lives of people living with cancer. We are committed to ensuring global access to our medicines, while focusing our research and development efforts on advancing medicines for hematologic, gastrointestinal and thoracic cancers.
Company name: Takeda
Address: 40 Landsdowne St, Cambridge, MA 02139
URL: www.takedaoncology.com
Corporate Supporters
BMS
Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular and neuroscience. Our employees work every day to transform patients’ lives through science.
Bristol Myers Squibb
3401 Princeton Pike
Lawrenceville, NJ 08648
Tel: 1-800-332-2056
Website: Global Biopharmaceutical Company – Bristol Myers Squibb
Pfizer
At Pfizer Oncology, we are at the forefront of a new era in cancer care. Our industry-leading portfolio and extensive pipeline includes three core mechanisms of action to attack cancer from multiple angles, including small molecules, antibody-drug conjugates (ADCs), and bispecific antibodies, including other immune-oncology biologics. We are focused on delivering transformative therapies in some of the world’s most common cancers, including breast cancer, genitourinary cancer, hematology-oncology, and thoracic cancers, which includes lung cancer. Driven by science, we are committed to accelerating breakthroughs to help people with cancer live better and longer lives.
Pfizer, Inc.
66 Hudson Boulevard East
New York, New York 10001
Tel: (212) 733-7300
Email: [email protected]
Website: www.pfizer.com
SOCIAL MEDIA Links:
https://www.linkedin.com/company/pfizer
https://twitter.com/PfizerCongress
https://twitter.com/pfizer
https://www.facebook.com/Pfizer
https://www.instagram.com/pfizerinc
